-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, OpFFbegLgBA2Br9jiqnn3As2o0le/ct+6CtHzVZtZHcvaAr9RwXzj91MFbHAK+vI nHwkZCuI31js7yjj1lLlwA== 0001209191-03-033346.txt : 20031203 0001209191-03-033346.hdr.sgml : 20031203 20031203133340 ACCESSION NUMBER: 0001209191-03-033346 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20031202 FILED AS OF DATE: 20031203 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: JEW JEANNE Y CENTRAL INDEX KEY: 0001235946 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-28298 FILM NUMBER: 031034817 BUSINESS ADDRESS: STREET 1: C/O ONYX PHARMECEUTICALS INC STREET 2: 3031 RESEARCH DR BLDG A CITY: RICHMOND STATE: CA ZIP: 94806 BUSINESS PHONE: 5102229700 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ONYX PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001012140 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 943154463 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3031 RESEARCH DR STREET 2: BLDG A CITY: RICHMOND STATE: CA ZIP: 94806 BUSINESS PHONE: 5102229700 MAIL ADDRESS: STREET 1: 3031 RESEARCH DRIVE CITY: RICHMOND STATE: CA ZIP: 94806 4 1 doc4.xml FORM 4 SUBMISSION X0201 42003-12-0200001012140ONYX PHARMACEUTICALS INC ONXX0001235946JEW JEANNE YC/O ONYX PHARMACEUTICALS, INC.3031 RESEARCH DR., BLDG. ARICHMONDCA948060100VP, Corporate & Commercial Dev Common Stock2003-12-024M015000.00006.4600A15000.0000DCommon Stock2003-12-024S0400.000029.8000D14600.0000DCommon Stock2003-12-024S01500.000029.7900D13100.0000DCommon Stock2003-12-02< /deemedExecutionDate>4S0300.000029.7800D12800.0000DCommon Stock2003-12-024S0300.000029.7700D12500.0000DCommon Stock2003-12-024S0100.000029.7600D12400.0000DCommon Stock2003-12-024S0700.000029.7400D11700.0000DCommon Stock2003-12-024S0100.000029.7300D11600.0000DCommon Stock2003-12-024S0500.000029.7200D11100.0000DCommon Stock2003-12-024S01400.000029.7000D9700.0000DCommon Stock2003-12-024S0100.000029.6400D9600.0000DCommon Stock2003-12-024S0100.000029.6000D9500.0000DCommon Stock2003-12-024S0100.000029.5800D9400.0000DCommon Stock2003-12-024S0600.000029.5500D8800.0000DCommon Stock2003-12-024S0200.000029.5050D8600.0000DCommon Stock 2003-12-024S0700.000029.5100D7900.0000DCommon Stock2003-12-024S0500.000029.5200D7400.0000DCommon Stock2003-12-024S0675.000029.5000D6725.0000DCommon Stock2003-12-024S0400.000029.4600D6325.0000DCommon Stock2003-12-024S0100.000029.4300D6225.0000DCommon Stock2003-12-024S05825.000029.4200D400.0000DCommon Stock2003-12-024S0100.000029.4100D300.0000DCommon Stock2003-12-024S0200.000029.4000D100.0000DCommon Stock2003-12-024S0100.000029.3200D0DStock Option (Right to Buy)6.46002003-12-024M015000.00000D2003-11-252013-11-25Common Stock15000.000085000.0000DThe option becomes exercisable as to 25% on the first anniversary of the date of grant and 1/48th monthly thereafter./s/ Marilyn E. Wortzman, Attorney-in-fact2003-12-02 -----END PRIVACY-ENHANCED MESSAGE-----